Skip to main content

ABI to Use Berry & Associates' Reagent with SOLiD Sequencer

NEW YORK (GenomeWeb News) – The biochemistry specialty company Berry & Associates said today that it will supply Applied Biosystems with a custom reagent for use with its SOLiD second-generation sequencer.
 
Under the five-year agreement, Berry & Associates said it will supply ABI with a custom nucleoside phosphoramidite that “meets the high purity standards required for synthesis of the oligonucleotide probes that are used in the SOLiD System.”
 
Berry & Associates is a private company based in Dexter, Mich., that offers custom nucleosides, nucleotides, monomers for DNA and RNA synthesis, fluorescent markers, and other biochemical agents.
 
Financial terms of the agreement were not released.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.